357 related articles for article (PubMed ID: 31068415)
1. Effects of histone deacetylase inhibitor Scriptaid and parathyroid hormone on osteocyte functions and metabolism.
Sun N; Uda Y; Azab E; Kochen A; Santos RNCE; Shi C; Kobayashi T; Wein MN; Divieti Pajevic P
J Biol Chem; 2019 Jun; 294(25):9722-9733. PubMed ID: 31068415
[TBL] [Abstract][Full Text] [Related]
2. Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulation.
Baertschi S; Baur N; Lueders-Lefevre V; Voshol J; Keller H
J Biol Chem; 2014 Sep; 289(36):24995-5009. PubMed ID: 25012661
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.
Li C; Wang W; Xie L; Luo X; Cao X; Wan M
Ann N Y Acad Sci; 2016 Jan; 1364(1):62-73. PubMed ID: 25847683
[TBL] [Abstract][Full Text] [Related]
4. HDAC5 controls MEF2C-driven sclerostin expression in osteocytes.
Wein MN; Spatz J; Nishimori S; Doench J; Root D; Babij P; Nagano K; Baron R; Brooks D; Bouxsein M; Pajevic PD; Kronenberg HM
J Bone Miner Res; 2015 Mar; 30(3):400-11. PubMed ID: 25271055
[TBL] [Abstract][Full Text] [Related]
5. SIKs control osteocyte responses to parathyroid hormone.
Wein MN; Liang Y; Goransson O; Sundberg TB; Wang J; Williams EA; O'Meara MJ; Govea N; Beqo B; Nishimori S; Nagano K; Brooks DJ; Martins JS; Corbin B; Anselmo A; Sadreyev R; Wu JY; Sakamoto K; Foretz M; Xavier RJ; Baron R; Bouxsein ML; Gardella TJ; Divieti-Pajevic P; Gray NS; Kronenberg HM
Nat Commun; 2016 Oct; 7():13176. PubMed ID: 27759007
[TBL] [Abstract][Full Text] [Related]
6. Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
Leupin O; Kramer I; Collette NM; Loots GG; Natt F; Kneissel M; Keller H
J Bone Miner Res; 2007 Dec; 22(12):1957-67. PubMed ID: 17696759
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the Class IIa HDAC Corepressor Complex Increases Energy Expenditure and Lipid Oxidation.
Gaur V; Connor T; Sanigorski A; Martin SD; Bruce CR; Henstridge DC; Bond ST; McEwen KA; Kerr-Bayles L; Ashton TD; Fleming C; Wu M; Pike Winer LS; Chen D; Hudson GM; Schwabe JWR; Baar K; Febbraio MA; Gregorevic P; Pfeffer FM; Walder KR; Hargreaves M; McGee SL
Cell Rep; 2016 Sep; 16(11):2802-2810. PubMed ID: 27626651
[TBL] [Abstract][Full Text] [Related]
8. Does osteocytic SOST suppression mediate PTH bone anabolism?
Kramer I; Keller H; Leupin O; Kneissel M
Trends Endocrinol Metab; 2010 Apr; 21(4):237-44. PubMed ID: 20074973
[TBL] [Abstract][Full Text] [Related]
9. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
[TBL] [Abstract][Full Text] [Related]
11. Effect of fluoride on osteocyte-driven osteoclastic differentiation.
Jiang N; Guo F; Xu W; Zhang Z; Jin H; Shi L; Zhang X; Gao J; Xu H
Toxicology; 2020 Apr; 436():152429. PubMed ID: 32156525
[TBL] [Abstract][Full Text] [Related]
12. Scriptaid cause histone deacetylase inhibition and cell cycle arrest in HeLa cancer cells: A study on structural and functional aspects.
Janaki Ramaiah M; Naushad SM; Lavanya A; Srinivas C; Anjana Devi T; Sampathkumar S; Dharan DB; Bhadra MP
Gene; 2017 Sep; 627():379-386. PubMed ID: 28668345
[TBL] [Abstract][Full Text] [Related]
13. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid Hormone Induces Bone Cell Motility and Loss of Mature Osteocyte Phenotype through L-Calcium Channel Dependent and Independent Mechanisms.
Prideaux M; Dallas SL; Zhao N; Johnsrud ED; Veno PA; Guo D; Mishina Y; Harris SE; Bonewald LF
PLoS One; 2015; 10(5):e0125731. PubMed ID: 25942444
[TBL] [Abstract][Full Text] [Related]
15. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.
Bellido T; Ali AA; Gubrij I; Plotkin LI; Fu Q; O'Brien CA; Manolagas SC; Jilka RL
Endocrinology; 2005 Nov; 146(11):4577-83. PubMed ID: 16081646
[TBL] [Abstract][Full Text] [Related]
16. N-cadherin restrains PTH repressive effects on sclerostin/SOST by regulating LRP6-PTH1R interaction.
Yang H; Dong J; Xiong W; Fang Z; Guan H; Li F
Ann N Y Acad Sci; 2016 Dec; 1385(1):41-52. PubMed ID: 27723935
[TBL] [Abstract][Full Text] [Related]
17. Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats.
Jia HB; Ma JX; Ma XL; Yu JT; Feng R; Xu LY; Wang J; Xing D; Zhu SW; Wang Y
Osteoporos Int; 2014 Dec; 25(12):2743-54. PubMed ID: 25074352
[TBL] [Abstract][Full Text] [Related]
18. A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction.
Sato T; Verma S; Andrade CDC; Omeara M; Campbell N; Wang JS; Cetinbas M; Lang A; Ausk BJ; Brooks DJ; Sadreyev RI; Kronenberg HM; Lagares D; Uda Y; Pajevic PD; Bouxsein ML; Gross TS; Wein MN
Nat Commun; 2020 Jul; 11(1):3282. PubMed ID: 32612176
[TBL] [Abstract][Full Text] [Related]
19. The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.
Spatz JM; Wein MN; Gooi JH; Qu Y; Garr JL; Liu S; Barry KJ; Uda Y; Lai F; Dedic C; Balcells-Camps M; Kronenberg HM; Babij P; Pajevic PD
J Biol Chem; 2015 Jul; 290(27):16744-58. PubMed ID: 25953900
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effect of histone deacetylase inhibitor scriptaid as a single agent for hepatocellular carcinoma.
Liu L; Sun X; Xie Y; Zhuang Y; Yao R; Xu K
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29945926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
